Company intelligence / Profile preview

The Fund

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

The Fund is a private venture capital and impact investing organization focused on supporting early-stage entrepreneurs rather than operating as a biotechnology, pharmaceutical, or healthcare company. It is described as a community of founders and operators that backs the next generation of local entrepreneurs. Available public information indicates it is based in New York and operates as an investor, not a drug developer or healthcare services provider. Accordingly, it does not appear to have a therapeutic pipeline, clinical-stage assets, or life-science operating programs.

Industry: Investors

Beyond the preview

Go deeper on The Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Fund.

Explore the full profile